- Home
- CFFI vs SRZN Comparison
CFFI vs SRZN Comparison
Compare CFFI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFFI | SRZN |
|---|---|---|
| Founded | 1927 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.2M | 271.6M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CFFI | SRZN |
|---|---|---|
| Price | $77.13 | $23.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 3.7K | ★ 100.3K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | ★ 37.94 | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $140,841,000.00 | N/A |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $37.67 | ★ N/A |
| Revenue Growth | ★ 10.63 | N/A |
| 52 Week Low | $60.76 | $8.00 |
| 52 Week High | $80.99 | $35.00 |
Technical Indicators
Market Signals| Indicator | CFFI | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 42.93 |
| Support Level | $69.84 | $20.26 |
| Resistance Level | $78.41 | $24.50 |
| Average True Range (ATR) | 1.77 | 2.04 |
| MACD | 0.32 | 0.24 |
| Stochastic Oscillator | 83.13 | 52.46 |
Price Performance
Historical ComparisonAbout CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).